BioSpace News Archive

Business

Curiox Biosystems Establishes a Scientific Advisory Board

Curiox Biosystems, Inc., a global leader in biological sample preparation for life science research, has formed a Scientific Advisory Board (SAB) to accelerate the company’s rapid expansion.

May 11, 2022
·
3 min read
I Peace accelerates allogeneic iPSC-derived cell therapies with a high throughput method to identify a large number of donors with specific HLA haplotypes

With this high-throughput method, the company has already succeeded in identifying 1,547 HLA-homozygous potential donors and has already generated iPSCs.

May 11, 2022
·
3 min read
Pharm Country

VESTECK, Inc. Delivers multiple presentations at Charring Cross International Symposium

VESTECK, Inc. is pleased to announce their participation and strong podium presence at the Charring Cross International Vascular Symposium.

May 11, 2022
·
2 min read
VectorY to Present Two Posters at the American Society of Gene and Cell Therapy’s (ASGCT) 25th Annual Meeting

VectorY to Present Two Posters at the American Society of Gene and Cell Therapy’s (ASGCT) 25th Annual Meeting.

May 11, 2022
·
1 min read
Deals

QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A.

QIAGEN N.V. announced that it has signed agreements to acquire a 96% majority ownership stake in BLIRT SA, a manufacturer of recombinant enzymes for the life science industry based in Gdansk, Poland.

May 11, 2022
·
6 min read
Hemlibra Sales Driving Global Bispecific Antibodies Market

Hemlibra is bispecific antibody which restores the hemostatic process and indicated for the routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patient’s ages newborn and older with hemophilia A with or without factor VIII inhibitors.

May 11, 2022
·
4 min read
Biotech Bay

Satsuma Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference

Satsuma Pharmaceuticals, Inc. announced that John Kollins, its President and Chief Executive Officer, will present at the H.C. Wainwright Global Investment Conference and invites investors to participate via webcast or in-person in Miami, FL on May 24 -25, 2022.

May 11, 2022
·
2 min read
Business

Clearside Biomedical Announces First Quarter 2022 Financial Results and Provides Corporate Update

Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), today reported financial results for the first quarter ended March 31, 2022 and provided a corporate update.

May 11, 2022
·
7 min read
Business

STRATA Skin Sciences Reports First Quarter 2022 Financial Results

STRATA Skin Sciences, Inc., a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced financial results for the first quarter ended March 31, 2022.

May 11, 2022
·
11 min read
Business

Marrone Bio Innovations, Inc. Reports First-Quarter 2022 Financial Results

Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financial results for the first quarter ended March 31, 2022.

May 11, 2022
·
13 min read